Inactivating loss-of-function mutations in GNAS cause pseudohypoparathyroidism type 1a (PHP1A), pseudopseudohypoparathyroidism, and progressive osseous heteroplasia [69]. The gene discussed is GNAS; the disease is pseudopseudohypoparathyroidism.